For example, we found that physical activity mediated part of the effect of PCSK9 inhibition on SLE risk, which could be explained by the fact that patients taking lipid-lowering drugs were more likely to engage in physical activity to help lower lipid levels. This evidence concerns the gene PCSK9 and systemic lupus erythematosus.